Eide T J
J Natl Cancer Inst. 1987 Aug;79(2):199-205.
A total of 6,202 patients with cancer of the uterine cervix was reported to the Cancer Registry in Norway from 1970 to 1984. Squamous cell carcinoma was reported in 86.1% of all cases, adenocarcinoma in 9.5%, and undifferentiated cancer in 3.6%; the heterogeneous group of "other malignant neoplasms" was 0.8% of all cases, most of which were sarcomas. During the 15-year period the average annual age-adjusted incidence rates for both squamous cell carcinoma and undifferentiated cancer decreased by 30 and 79%, respectively, whereas adenocarcinoma increased by 38%. The increase of adenocarcinoma was mostly confined to females 20-34 years of age. The decrease in incidence rates of undifferentiated cancer was observed in all age groups, whereas the fall in incidence rates for squamous cell carcinoma was demonstrated in females above 35 years of age only. Of all patients with squamous cell carcinoma, 55% were diagnosed in clinical stage I. Females with adenocarcinoma and undifferentiated cancer were diagnosed in stage I in 60 and 38% of the cases, respectively. The 5- and 10-year relative survival rates were highest for patients with squamous cell carcinoma at all stages, whereas a significantly less favorable prognosis was found for females with adenocarcinoma and undifferentiated cancer of the uterine cervix.
1970年至1984年期间,挪威癌症登记处共报告了6202例子宫颈癌患者。所有病例中,鳞状细胞癌占86.1%,腺癌占9.5%,未分化癌占3.6%;“其他恶性肿瘤”这一异类组占所有病例的0.8%,其中大多数为肉瘤。在这15年期间,鳞状细胞癌和未分化癌的年龄调整年均发病率分别下降了30%和79%,而腺癌则上升了38%。腺癌的增加主要局限于20至34岁的女性。未分化癌发病率的下降在所有年龄组中均有观察到,而鳞状细胞癌发病率的下降仅在35岁以上的女性中出现。在所有鳞状细胞癌患者中,55%在临床I期被诊断出来。腺癌和未分化癌女性患者分别有60%和38%在I期被诊断出来。鳞状细胞癌患者在所有阶段的5年和10年相对生存率最高,而子宫颈腺癌和未分化癌女性患者的预后则明显较差。